Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$710M |
| 2 |
Samsara
IOT
|
+$298M |
| 3 |
Moderna
MRNA
|
+$277M |
| 4 |
SolarEdge
SEDG
|
+$272M |
| 5 |
Pool Corp
POOL
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$439M |
| 2 |
Illumina
ILMN
|
+$351M |
| 3 |
FRC
First Republic Bank
FRC
|
+$333M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$303M |
| 5 |
NVIDIA
NVDA
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.82% |
| 2 | Healthcare | 22.38% |
| 3 | Technology | 21.54% |
| 4 | Communication Services | 11.88% |
| 5 | Financials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Alector
ALEC
$199M
| $2.41M | ﹤0.01% |
390,113
+4,156
| +1% | +$33.8K |
|
|
MTLS
252
Materialise
MTLS
$396M
| $2.22M | ﹤0.01% |
268,000
| – | – |
|
253
HUTCHMED
HCM
$2.17B
| $1.98M | ﹤0.01% |
152,225
| – | – |
|
254
Agnico Eagle Mines
AEM
$90.5B
| $1.91M | ﹤0.01% |
37,548
+11,125
| +42% | +$571K |
|
255
Newmont
NEM
$119B
| $1.86M | ﹤0.01% |
37,848
+11,889
| +46% | +$576K |
|
256
Lyell Immunopharma
LYEL
$360M
| $1.8M | ﹤0.01% |
38,066
| – | – |
|
257
Golub Capital BDC
GBDC
$3.42B
| $1.66M | ﹤0.01% |
122,100
| – | – |
|
258
Wheaton Precious Metals
WPM
$60.9B
| $1.57M | ﹤0.01% |
32,616
+12,200
| +60% | +$533K |
|
|
CELL
259
DELISTED
PhenomeX Inc. Common Stock
CELL
| $1.56M | ﹤0.01% |
1,346,882
-419
| -0% | -$766 |
|
260
Sixth Street Specialty
TSLX
$1.81B
| $1.45M | ﹤0.01% |
79,500
| – | – |
|
261
MongoDB
MDB
$32.1B
| $1.45M | ﹤0.01% |
6,239
+2,611
| +72% | +$548K |
|
262
MaxCyte
MXCT
$126M
| $1.41M | ﹤0.01% |
293,325
| – | – |
|
263
Novanta
NOVT
$6.29B
| $1.25M | ﹤0.01% |
7,845
-93
| -1% | -$14.3K |
|
264
WEC Energy
WEC
$35.1B
| $1.08M | ﹤0.01% |
11,353
| – | – |
|
265
Adicet Bio
ACET
$74.7M
| $1.05M | ﹤0.01% |
11,352
| – | – |
|
266
Ameren
AEE
$30.1B
| $1.02M | ﹤0.01% |
11,802
| – | – |
|
267
Fortis
FTS
$28.7B
| $1.02M | ﹤0.01% |
23,917
| – | – |
|
268
Exelon
EXC
$47B
| $958K | ﹤0.01% |
22,861
| – | – |
|
269
Xencor
XNCR
$1.55B
| $886K | ﹤0.01% |
31,754
-301
| -0.9% | -$9.28K |
|
270
Coinbase
COIN
$40.5B
| $866K | ﹤0.01% |
12,815
+5,321
| +71% | +$319K |
|
271
Smartbird Inc
BIRD
$22.3M
| $639K | ﹤0.01% |
26,625
-41,779
| -61% | -$1.93M |
|
272
CarGurus
CARG
$3.47B
| $599K | ﹤0.01% |
32,059
-418
| -1% | -$7.11K |
|
273
Spire Global
SPIR
$555M
| $579K | ﹤0.01% |
108,256
| – | – |
|
274
Varonis Systems
VRNS
$5B
| $570K | ﹤0.01% |
21,932
-730
| -3% | -$19K |
|
275
Calix
CALX
$2.39B
| $562K | ﹤0.01% |
10,492
-134
| -1% | -$7.3K |
|
Similar funds
Baillie Gifford & Co's Q1 2023 Portfolio in Review
As of Q1 2023, Baillie Gifford & Co held 493 positions worth $111B, up 15% from $96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Baillie Gifford & Co's Q1 2023 filing shows 5 new, 168 increased, 169 reduced and 39 closed positions. Its largest new stake was Samsara: 18,813,062 shares worth $371M. The largest sale was Salesforce, an estimated $439M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Baillie Gifford & Co's largest Q1 2023 buy was Samsara: 18,813,062 shares worth $371M.
- Baillie Gifford & Co added most to Advanced Micro Devices in Q1 2023, an estimated $710M increase.
- Baillie Gifford & Co's biggest Q1 2023 reduction was Illumina, cutting an estimated $351M.
- Baillie Gifford & Co fully exited Salesforce in Q1 2023, selling an estimated $439M.
- Baillie Gifford & Co's ten largest holdings make up 40% of its $111B portfolio in Q1 2023.
- Baillie Gifford & Co opened 5 new positions and closed 39 in Q1 2023.
- Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $111B.
Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.